European Archives - Page 496 of 1165 - European Medical Journal

Unpicking pharma’s reputation in pop culture

Helena is joined by Paul Simms, CEO, Impatient Health, to delve deeper into GOLD’s cover feature on reframing pharma’s bad boy reputation.

Spencer Gore named among UK’s Top 50 Most Ambitious Business Leaders for 2022

Spencer Gore, Founder of EMJ has been named as one of The LDC Top 50 Most Ambitious Business Leaders for 2022.

Overview of Obstructive Hypertrophic Cardiomyopathy

This episode explores various aspects of obstructive hypertrophic cardiomyopathy (HCM), and features expert insights from Antonis Pantazis.

Spotlight on MTX therapy in patients with RA – increasing vaccination response and combination therapy

In this podcast, listeners can expect two highly interesting interviews with two well-known experts in the field of rheumatoid arthritis.

An Observational Study on Unique High Resolution Computed Tomography Pattern of Post-COVID Pulmonary Fibrosis

The parenchyma of the lungs can undergo fibrosis due to known aetiology such as radiation or drug induced fibrosis; occupational or connective tissue related interstitial lung disease; or it may have genetic basis or remain idiopathic, as in idiopathic pulmonary fibrosis.

Cancer Prevention and Early Detection

This week, our host Jonathan Sackier is joined by David Crosby to discuss prevention and early detection of cancer.

Promising outlook for integrating young talent in pharma

Collaboration between the pharmaceutical industry and academia is on the rise, according to a recent survey from the ABPI.

Pfizer-BioNTech assemble with the Avengers in COVID booster drive

Pfizer and BioNTech collaborate with Marvel on a comic encouraging COVID-19 booster vaccinations in the US.

EMJ Cardiology 10.1 2022 Feature Image

Artificial Intelligence-Guided Single-Lead ECG May Be a Game-Changer for Symptom-to-Balloon Time Reduction in ST-Elevated Myocardial Infarction

Comprehending the rate at which ischaemic myocardium succumbs to necrosis following an abrupt occlusion of a coronary artery is crucial to understand the efficacy and benefits behind the time dependency in ST-elevated myocardial infarction (STEMI) management. Over decades, efforts to shave off life-saving minutes from STEMI care centred on reducing door-to-needle and door-to-balloon times.

EMJ Cardiology 10.1 2022 Feature Image

EMJ Cardiology 10.1 2022

The latest edition of EMJ Cardiology is out now, sharing novel case studies and outlining key advances in scientific understanding through reviews and research articles. Featured articles include artificial intelligence in screening for heart disease, idarucizumab in emergent pericardiocentesis, and more. Reviewing the European Society of Cardiology (ESC) 2022 Congress, this issue covers the latest breaking news and updates in the field of cardiology.